This report focuses on the global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-insulin Diabetes Therapeutics development in United States, Europe and China. Non-insulin diabetes therapeutics are mostly administered orally and prescribed when diet and exercise are insufficient to control elevated blood glucose levels. In 2017, the global Non-insulin Diabetes Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. The key players covered in this study GSK Eli Lilly Sumitomo Dainippon Pharma Intarcia Therapeutics Servier Jiangsu Hansoh Pharmaceutical Novo Nordisk Emisphere Uni-Bio Science Group Takeda 3SBio Merck Dong-A Pharmaceutical Luye Pharma Group Eurofarma Geropharm Alkem Labs SatRx Pfizer Market segment by Type, the product can be split into DPP4 inhibitor GLP-1 agonist SGLT2 inhibitor Market segment by Application, split into Hospital Pharmacy Retail Pharmacies Online Pharmacy Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Non-insulin Diabetes Therapeutics status, future forecast, growth opportunity, key market and key players. To present the Non-insulin Diabetes Therapeutics development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Non-insulin Diabetes Therapeutics are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Non-insulin Diabetes Therapeutics Market Size Growth Rate by Type (2013-2025) 1.4.2 DPP4 inhibitor 1.4.3 GLP-1 agonist 1.4.4 SGLT2 inhibitor 1.5 Market by Application 1.5.1 Global Non-insuli
